Delivery Order SPE2DB22D2006-SPE2DB25FV8ZV
Award Date
3/10/25
Potential Completion Date
3/11/25
Potential Value
$8.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,501.46, is for the delivery of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication, to support military healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, valued at $35,313.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a pharmaceutical product, with a completion date of February 10, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,282.36 firm fixed-price contract is for the delivery of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of July 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,898.67 firm fixed-price delivery order is for TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a pharmaceutical product. The contract has a completion date of November 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $3,319.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication, to support military healthcare programs. The award is a Firm Fixed Price Delivery Order, with a performance period extending through March 3, 2025. AmerisourceBergen holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,669.19 firm fixed-price delivery order is for the supply of 4564847169 TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of June 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award SPE2DB20D1100|SPE2DB24FC8V7 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,748.20 firm-fixed-price delivery order is for 4565229764 TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication. The contract has an ultimate completion date of July 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $16,260.61 and is for the delivery of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is a delivery order under an Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,011.51 fixed-price delivery order is for 4566735327 TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication. The contract has a completion date of December 17, 2024 and is not set aside. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, valued at $56,821.15, is a Firm Fixed Price Delivery Order contract for the supply of Telmisartan-HCTZ 40-12.5 mg tablets. The contract has an ultimate completion date of November 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...